These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


800 related items for PubMed ID: 19100777

  • 1. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH.
    Immunol Lett; 2009 Feb 21; 122(2):108-11. PubMed ID: 19100777
    [Abstract] [Full Text] [Related]

  • 2. Improving vaccine performance with adjuvants.
    Vogel FR.
    Clin Infect Dis; 2000 Jun 21; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y, Mohammed AR, Kirby DJ, McNeil SE, Bramwell VW.
    Int J Pharm; 2008 Dec 08; 364(2):272-80. PubMed ID: 18555624
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adjuvants in perspective.
    Vogel FR.
    Dev Biol Stand; 1998 Dec 08; 92():241-8. PubMed ID: 9554280
    [Abstract] [Full Text] [Related]

  • 8. Translating innate immunity into immunological memory: implications for vaccine development.
    Pulendran B, Ahmed R.
    Cell; 2006 Feb 24; 124(4):849-63. PubMed ID: 16497593
    [Abstract] [Full Text] [Related]

  • 9. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G.
    Vaccine; 2010 Aug 31; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [Abstract] [Full Text] [Related]

  • 10. New adjuvants for human vaccines.
    Mbow ML, De Gregorio E, Valiante NM, Rappuoli R.
    Curr Opin Immunol; 2010 Jun 31; 22(3):411-6. PubMed ID: 20466528
    [Abstract] [Full Text] [Related]

  • 11. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B, Navabi H, Adams M.
    Vaccine; 2009 May 26; 27(25-26):3401-4. PubMed ID: 19200817
    [Abstract] [Full Text] [Related]

  • 12. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J, Egan W, Vicari G, Furesz J, Schild G.
    Biologicals; 2007 Apr 26; 35(2):107-13. PubMed ID: 16882459
    [Abstract] [Full Text] [Related]

  • 13. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH, Wang XY, Dennis CG, Youn R, Repasky EA, Manjili MH, Subjeck JR.
    Drug Discov Today; 2006 Jun 26; 11(11-12):534-40. PubMed ID: 16713905
    [Abstract] [Full Text] [Related]

  • 14. On immunity against infections and vaccines: credo 2004.
    Zinkernagel RM, Hengartner H.
    Scand J Immunol; 2004 Jun 26; 60(1-2):9-13. PubMed ID: 15238068
    [Abstract] [Full Text] [Related]

  • 15. Cancer vaccines: challenges and outlook in the field.
    Paul S, Acres B, Limacher JM, Bonnefoy JY.
    IDrugs; 2007 May 26; 10(5):324-8. PubMed ID: 17487784
    [Abstract] [Full Text] [Related]

  • 16. The potential of oral vaccines for disease control in wildlife species.
    Cross ML, Buddle BM, Aldwell FE.
    Vet J; 2007 Nov 26; 174(3):472-80. PubMed ID: 17113798
    [Abstract] [Full Text] [Related]

  • 17. The relevance of cytokines for development of protective immunity and rational design of vaccines.
    Chabalgoity JA, Baz A, Rial A, Grille S.
    Cytokine Growth Factor Rev; 2007 Nov 26; 18(1-2):195-207. PubMed ID: 17347024
    [Abstract] [Full Text] [Related]

  • 18. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M, Meeusen E.
    Discov Med; 2011 Sep 26; 12(64):195-204. PubMed ID: 21955847
    [Abstract] [Full Text] [Related]

  • 19. The science of adjuvants.
    Kwissa M, Kasturi SP, Pulendran B.
    Expert Rev Vaccines; 2007 Oct 26; 6(5):673-84. PubMed ID: 17931149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.